⌘K

Login Start Free

Home/Filings/4/0001140361-21-008183

4//SEC Filing

SORIANO JOHN 4

Accession 0001140361-21-008183

CIK 0001104506other

View on SEC.gov Company Profile

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 4:12 PM ET

Size

23.0 KB

Accession

0001140361-21-008183

Insider Transaction Report

Form 4

Period: 2021-03-09

Chief Compliance Officer

Transactions

Exercise/Conversion
Stock Option (right to buy)
2021-03-09−13,433→ 36,767 total
Exercise: $30.86Exp: 2028-01-22→ Common Stock (13,433 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-03-10−500→ 36,267 total
Exercise: $30.86Exp: 2028-01-22→ Common Stock (500 underlying)
Sale
Common Stock
2021-03-09$40.38/sh−14,130$570,569→ 29,773 total
Exercise/Conversion
Common Stock
2021-03-10$30.86/sh+500$15,430→ 30,273 total
Sale
Common Stock
2021-03-10$40.00/sh−500$20,000→ 29,773 total
Exercise/Conversion
Stock Option (right to buy)
2021-03-09−17,349→ 69,395 total
Exercise: $13.91Exp: 2029-01-03→ Common Stock (17,349 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-03-09−14,130→ 42,390 total
Exercise: $23.75Exp: 2030-01-03→ Common Stock (14,130 underlying)
Exercise/Conversion
Common Stock
2021-03-09$30.86/sh+13,433$414,542→ 43,206 total
Sale
Common Stock
2021-03-09$40.38/sh−13,433$542,425→ 29,773 total
Sale
Common Stock
2021-03-09$40.38/sh−17,349$700,553→ 29,773 total
Exercise/Conversion
Common Stock
2021-03-09$23.75/sh+14,130$335,588→ 43,903 total
Exercise/Conversion
Common Stock
2021-03-09$13.91/sh+17,349$241,325→ 47,122 total

Footnotes (3)

[F1]This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
[F2]This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
[F3]The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

INSMED Inc

CIK 0001104506

Entity typeother

Related Parties

1

filerCIK 0001740947

Filing Metadata

Form type: 4
Filed: Mar 10, 7:00 PM ET
Accepted: Mar 11, 4:12 PM ET
Size: 23.0 KB

View on SEC.gov